Related references
Note: Only part of the references are listed.Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease
Eliot A. Brinton
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2016)
Low Testosterone: A Risk Marker Rather Than a Risk Factor for Type 2 Diabetes
Stine A. Holmboe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Testosterone supplementation and body composition: results from a meta-analysis of observational studies
G. Corona et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Visceral fat dysfunction is positively associated with hypogonadism in Chinese men
Ningjian Wang et al.
SCIENTIFIC REPORTS (2016)
Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both
Shawn Riser Taylor et al.
PHARMACOTHERAPY (2015)
Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Xiang Cai et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
Effect of Testosterone Treatment on Constitutional and Sexual Symptoms in Men With Type 2 Diabetes in a Randomized, Placebo-Controlled Clinical Trial
Emily J. Gianatti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Testosterone Replacement Therapy Improves Metabolic Parameters in Hypogonadal Men with Type 2 Diabetes but Not in Men with Coexisting Depression: The BLAST Study
Geoffrey Hackett et al.
JOURNAL OF SEXUAL MEDICINE (2014)
LDL cholesterol: controversies and future therapeutic directions
Paul M. Ridker
LANCET (2014)
Effects of Long-Term Testosterone Therapy on Patients with Diabesity: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
Ahmad Haider et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A. Hegele et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency
Shota Janjgava et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2014)
The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism
S. A. Saboor Aftab et al.
CLINICAL ENDOCRINOLOGY (2013)
Pathophysiology of Atherosclerosis Plaque Progression
Kenichi Sakakura et al.
HEART LUNG AND CIRCULATION (2013)
High-density lipoproteins: A consensus statement from the National Lipid Association
Peter P. Toth et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2013)
Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies
Jun Liu et al.
LIPIDS IN HEALTH AND DISEASE (2013)
被撤回的出版物: Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review (Retracted article. See vol. 47, pg. 1919, 2015)
Wayne J. G. Hellstrom et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2012)
Characteristics of Androgen Deficiency in Late-Onset Hypogonadism: Results from the European Male Aging Study (EMAS)
Abdelouahid Tajar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
T. Hugh Jones et al.
DIABETES CARE (2011)
Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
Christina Wang et al.
DIABETES CARE (2011)
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
Andre B. Araujo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study
Svetlana Y. Kalinchenko et al.
CLINICAL ENDOCRINOLOGY (2010)
TREATMENT OF HYPOGONADISM WITH TESTOSTERONE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Raju A. Gopal et al.
ENDOCRINE PRACTICE (2010)
Effects of Testosterone Undecanoate on Cardiovascular Risk Factors and Atherosclerosis in Middle-Aged Men with Late-Onset Hypogonadism and Metabolic Syndrome: Results from a 24-month, Randomized, Double-Blind, Placebo-Controlled Study
Antonio Aversa et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
LANCET (2010)
Testosterone deficiency: a risk factor for cardiovascular disease?
T. H. Jones
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Remnant-like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism
Ling Liu et al.
ATHEROSCLEROSIS (2009)
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Abdulmaged M. Traish et al.
JOURNAL OF ANDROLOGY (2009)
Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
C. Wang et al.
JOURNAL OF ANDROLOGY (2009)
Fifty-two-Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabetes and Subnormal Plasma Testosterone
Armin E. Heufelder et al.
JOURNAL OF ANDROLOGY (2009)
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation
Limin Wang et al.
JOURNAL OF LIPID RESEARCH (2009)
Low testosterone levels are common and associated with insulin resistance in men with diabetes
Mathis Grossmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Low levels of androgens in men with erectile dysfunction and obesity
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2008)
Lysosomal cholesterol accumulation inhibits subsequent hydrolysis of lipoprotein cholesteryl ester
W. Gray Jerome et al.
MICROSCOPY AND MICROANALYSIS (2008)
Translating molecular discoveries into new therapies for atherosclerosis
Daniel J. Rader et al.
NATURE (2008)
Aging, androgens, and the metabolic syndrome in a longitudinal study of aging
Annabelle Rodriguez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction
Andre Guay et al.
JOURNAL OF SEXUAL MEDICINE (2007)
Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis
Eiji Matsuura et al.
PROGRESS IN LIPID RESEARCH (2006)
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
D. Kapoor et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis
AM Isidori et al.
CLINICAL ENDOCRINOLOGY (2005)
Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study
AB Araujo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host
W Khovidhunkit et al.
JOURNAL OF LIPID RESEARCH (2004)
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes
S Dhindsa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
New perspectives on atherogenesis role of abnormal triglyceride-rich lipoprotein metabolism
HN Ginsberg
CIRCULATION (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Validation of a screening questionnaire for androgen deficiency in aging males
JE Morley et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Share Paper
